Kingsview Wealth Management’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.08M Buy
3,819
+441
+13% +$128K 0.01% 673
2025
Q4
$999K Buy
3,378
+306
+10% +$92.2K 0.01% 640
2025
Q3
$757K Sell
3,072
-1,861
-38% -$375K 0.01% 679
2025
Q2
$770K Buy
4,933
+702
+17% +$74.6K 0.01% 646
2025
Q1
$333K Sell
4,231
-714
-14% -$75.7K 0.01% 851
2024
Q4
$456K Buy
+4,945
New +$387K 0.01% 774
2024
Q3
Sell
-5,019
Closed -$288K 1104
2024
Q2
$288K Sell
5,019
-1,340
-21% -$67.6K 0.01% 854
2024
Q1
$286K Buy
+6,359
New +$241K 0.01% 834

Other funds holding CLS

Kingsview Wealth Management's CLS Position: Q1 2026 in Review

Kingsview Wealth Management increased its Celestica (CLS) stake by 13% in Q1 2026, buying an estimated $128K and bringing the position to 3,819 shares worth $1.08M. The position accounts for 0.01% of the portfolio, ranked #673.

Kingsview Wealth Management first reported a position in CLS in Q1 2024 and has held it in 8 quarters since. 773 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

  • Kingsview Wealth Management held 3,819 shares of Celestica worth $1.08M as of Q1 2026.
  • Kingsview Wealth Management bought 441 Celestica shares in Q1 2026, an estimated $128K.
  • Celestica made up 0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #673 holding.
  • Kingsview Wealth Management first reported a position in Celestica in Q1 2024 and has held it in 8 quarters since.
  • 773 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.